Executive Summary
Across 50 US SEC 8-K filings dated March 12, 2026, dominant themes include widespread board expansions and executive appointments (20+ instances, e.g., healthcare/tech sectors), signaling proactive governance refreshes amid growth ambitions. Capital raising activity is robust with 15+ financings/debt deals totaling >$3B (e.g., CACI $500M notes, NGL $950M term loan, Longeveron $30M PP), extending runways and refinancing maturities, though some mixed with dilution/waivers. M&A completions/ announcements (8 filings, e.g., Laird $38.5M Navitas, T Stamp dual acqs) highlight consolidation in consumer health/tech, while operational distress appears isolated (Vestand closures/resignations). No aggregate YoY/QoQ financial trends due to 8-K focus on events, but capital allocation leans toward debt optimization (10+ refinancings) over dividends/buybacks. Bullish sentiment prevails (60% positive/neutral), with healthcare (Longeveron trial data 3Q26) and fintech leading; bearish outliers in retail/food (Vestand). Implications: Favor liquidity-strong firms pre-earnings; monitor SPACs/mergers for catalysts. Portfolio pattern: Activist settlements (Turtle Beach) and CEO transitions (Build-A-Bear) indicate stabilizing managements.
Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from March 11, 2026.
Investment Signals(12)
- Longeveron Inc.↓(BULLISH)▲
$30M PP ($15M upfront + $15M milestone-tied to 3Q26 ELPIS II data), extends runway to 4Q26, led by top investors
- Laird Superfood, Inc.↓(BULLISH)▲
Completed $38.5M Navitas acquisition funded by $50M preferred stock PP, creates scaled functional nutrition platform with synergies
- CACI International Inc.↓(BULLISH)▲
Issued $500M 6.375% notes due 2033 for ARKA acquisition debt repay, net proceeds $518M, total outstanding $1.5B
- Hanover Bancorp, Inc.↓(BULLISH)▲
$35M subordinated notes PP at 7.25% fixed-to-floating, Tier 2 capital for $25M prior notes redemption + growth, BBB+ rated
- T Stamp Inc↓(BULLISH)▲
Closed Lexverify 100% + Cyberfish 50% acqs, NCSC alumni targets add AI cybersecurity synergies, leadership integration for 2026 growth
- Applied Optoelectronics, Inc.↓(BULLISH)▲
Doubled ATM offering capacity to $500M after selling ~$250M (2.47M shares), 2% agent fee, enhances liquidity
- Firefly Neuroscience, Inc.↓(BULLISH)▲
$2.25M initial PP close (1.5M units @ $1.50), up to $20.25M more in 30 days, Nasdaq compliant with lock-ups
- Build-A-Bear Workshop Inc.↓(BULLISH)▲
Planned CEO succession to Chris Hurt (internal COO), post-record FY25 $529.8M rev, multi-year process
- iRhythm Technologies, Inc.↓(BULLISH)▲
Appointed UnitedHealth EVP Jason Patten to board, expertise in healthcare strategy/AI for $1B platform growth
- Quest Diagnostics Inc.↓(BULLISH)▲
Elected ex-Walgreens CEO Timothy Wentworth to board, adds healthcare ops/HR expertise amid 57K employees
- Blue Ridge Bankshares, Inc.↓(BULLISH)▲
CEO retirement post-OCC exit/profitability restore, interim CEO Harry Golliday (credit expert) for growth phase
- Paycom Software, Inc.↓(BULLISH)▲
Multiple banks increased revolver commitments (JPM, BMO etc.), no defaults, boosts liquidity under 2022 credit agreement
Risk Flags(10)
- Vestand Inc./Exec Departures↓[HIGH RISK]▼
Director/CCO Andrew Yun resigned citing direction concerns/unheeded advice, Dir Abe Lim resigned, 12 restaurant closures + lease defaults
- ▼
Merger with Gravitics gives targets 95.5% equity, existing holders <=4.5%, closes by Jun 30 2026
- XBP Global Holdings, Inc./Credit Waiver↓[MEDIUM RISK]▼
ABL amendment waives $7.5M excess availability covenant but adds availability block if FCCR <1.0x thru Jun 30 2026
- NGL Energy Partners LP/Debt Restructure↓[MEDIUM RISK]▼
$950M term loan repay/redeem prefs but ABL cut $50M to $425M, limits liquidity despite simpler structure
- Chemours Co/Debt Refi↓[MEDIUM RISK]▼
$700M 7.875% notes due 2034 to redeem lower-coupon 2027/2028 notes, higher rates extend maturities
- IGC Pharma, Inc./Dilutive Financing↓[MEDIUM RISK]▼
$353k bridge note (46k OID) convertible, up to $2M more, vs 92.8M shares out of 600M authorized
- B. Riley Financial, Inc./Reporting Delay↓[MEDIUM RISK]▼
Debt retirement $37.9M via exchanges but 10-K extension to Mar 31 via 12b-25 due to auditor change
- Turtle Beach Corp/Activist Settlement↓[LOW RISK]▼
Board expand to 8, Donerail cap 9.9%, standstill/voting aligns but terminable on merger/breach
- ▼
CFO Coogan departs Apr 24 2026, IR SVP Ryzhik interim amid Veeco merger
- Colgate-Palmolive Co/Director Loss↓[LOW RISK]▼
Steven Cahillane not for re-election due to Kraft Heinz CEO role, offset by BMS CEO add
Opportunities(10)
- Longeveron Inc./Trial Catalyst↓(OPPORTUNITY)◆
$30M PP funds past 3Q26 ELPIS II HLHS topline, milestone unlock + PRV sale interest
- Laird Superfood, Inc./M&A Synergies↓(OPPORTUNITY)◆
Navitas integration for superfoods scale, stockholder approved Mar 11, Nexus PMT funding
- T Stamp Inc./Cybersecurity Expansion↓(OPPORTUNITY)◆
Lexverify/Cyberfish acqs add AI/LLM sims, cross-sell in banking/govt/healthcare
- Plum Acquisition Corp IV/SPAC Merger↓(OPPORTUNITY)◆
BCA with Controlled Thermal Resources, 60% stockholder support, domestication + merger
- Applied Optoelectronics, Inc./ATM Upsize↓(OPPORTUNITY)◆
$250M remaining capacity post-initial sales, at-market Nasdaq for flexible capital
- Hanover Bancorp/ Capital Strengthen↓(OPPORTUNITY)◆
$35M notes redeem higher-rate debt, Tier 2 boost for balance sheet growth
- Build-A-Bear/Leadership Continuity↓(OPPORTUNITY)◆
Internal CEO Hurt post-turnaround, record FY25 rev $529.8M, global expansion
- Firefly Neuroscience/Additional Funding↓(OPPORTUNITY)◆
$18M investor option in 30 days post-$2.25M close, S-1 by Apr 15
- CACI International/Acquisitive Growth↓(OPPORTUNITY)◆
$500M notes fund ARKA integration, private placement success
- Southwest Airlines/Credit Access↓(OPPORTUNITY)◆
$500M term loan (expandable $500M more) secured by aircraft, SOFR+110bps to 2029
Sector Themes(6)
- Healthcare Board Refresh◆
8/12 healthcare filings (iRhythm, Quest, Acadia, Enanta, Avanos, Longeveron, Firefly) show director adds/re-elections, avg materiality 7/10, signals expertise infusion for AI/clinical growth vs sector turnover
- Financing Frenzy in Small Caps◆
18/50 filings (Longeveron $30M, Firefly $20M+, Applied $500M ATM) PP/ATM/notes total >$2.5B, positive sentiment 70%, extends runways amid no YoY data but pre-clinical catalysts
- Debt Optimization Wave◆
12 firms (CACI $500M, NGL $950M, Chemours $700M, Hanover $35M) refinanced/extended maturities, mixed rates higher but simpler structures, 9/10 positive for liquidity vs equity dilution
- Retail/Consumer Distress Signals◆
Vestand closures/resignations (neg 9/10), contrast Build-A-Bear record rev succession (pos 9/10), Laird M&A scale-up; watch ops losses vs turnaround plays
- Tech/GovCon M&A Momentum◆
T Stamp cyber acqs, CACI ARKA, Axcelis Veeco pending; 6 filings avg materiality 9/10, synergies in AI/security outweigh interim CFO risks
- Banking Exec Stability◆
Blue Ridge CEO transition post-OCC exit, Hanover/FIRST UNITED LTIP tweaks (ROAE/TBVPSG peers), positive capital allocation vs XBP covenant waivers
Watch List(8)
3Q26 topline data + $15M milestone unlock, initial PP close Mar 11 [Q3 2026]
Monitor further closures post-12 sites, Yun resignation details Exhibit 17.1 [Ongoing]
Closing by Jun 30 2026, 95.5% dilution impact on shareholder vote [Jun 30 2026]
Search firm engaged post-Ryzhik interim, amid Veeco merger [Apr 24 2026 transition]
12b-25 filed Mar 17, Q4/FY25 results + call next week by Mar 31 [Mar 17-31 2026]
Shareholder approval at annual meeting, holding co conversion [2026 Annual Mtg]
Hurt assumes role post-John retirement, board continuity [Jun 11 2026]
Registration by Apr 15, effectiveness 45-90 days for warrants/shares [Apr 15 2026]
Filing Analyses(50)
12-03-2026
Turtle Beach Corporation entered into a Cooperation Agreement with the Donerail Group (TDG CP LLC, The Donerail Group Inc., The Donerail Group & Co LLC, and William Wyatt) on March 9, 2026, to expand its Board from six to eight members within 30 days and appoint two new independent directors selected by the group, while naming William Wyatt as Chairman. The agreement mandates nominating specific incumbent directors at the 2026 Annual Meeting, includes standstill provisions capping Donerail's ownership at 9.9%, voting alignments with the Board (or ISS/Glass Lewis in some cases), and mutual releases/non-disparagement. No financial impacts are disclosed, representing a governance settlement without operational or performance metrics.
- ·Donerail Group agrees to vote with Board recommendations at stockholder meetings (except certain Board matters; may follow ISS or Glass Lewis if differing).
- ·Customary standstill provisions prohibit proxy solicitations, groups, or public criticism of management/directors.
- ·Agreement terminable on 5 business days' notice after specified date, or immediately upon extraordinary transaction (e.g., merger) or material breach.
12-03-2026
Longeveron Inc. entered a definitive agreement for a private placement raising up to $30M gross proceeds ($15M upfront, additional $15M milestone-driven tied to Phase 2b ELPIS II HLHS trial), led by Coastlands Capital with Janus Henderson Investors, Logos Capital, and Kalehua Capital. Initial proceeds extend cash runway into 4Q26, past anticipated 3Q26 topline data readout for ELPIS II. H.C. Wainwright & Co. acted as exclusive placement agent; securities issued include 6M+ common shares and preferred shares convertible into 22.8M+ shares at $0.52.
- ·Shares priced at $0.52 per share for common stock; Preferred Shares at $1,000 each with $0.52 conversion price
- ·Investors receive 50% interest in net proceeds from potential future Rare Pediatric Disease Priority Review Voucher sale related to HLHS program
- ·Initial closing expected on or about March 11, 2026
- ·Proceeds for clinical/regulatory development of laromestrocel, working capital, and general corporate purposes
12-03-2026
Andrew Yun resigned as Director and Chief Compliance Officer on February 27, 2026, citing concerns about the Company’s direction and unheeded advice on Board approvals and counsel. Abe Lim resigned as Director on March 3, 2026, without any stated disagreements. On March 2, 2026, the Board approved a temporary suspension of restaurant operations to address ongoing losses, closing 12 locations with potential for more closures and several in lease defaults.
- ·Company’s California restaurants at Buena Park, Eastvale, La Mirada, Irvine, and Ontario are in lease-related defaults.
- ·Resignation letter of Andrew Yun filed as Exhibit 17.1.
12-03-2026
Enanta Pharmaceuticals held its Annual Meeting on March 11, 2026, where stockholders re-elected directors Bruce L.A. Carter, Ph.D. and Jay R. Luly, Ph.D.; approved an amendment to the 2019 Equity Incentive Plan to increase reserved shares by 1,600,000 despite 5,390,888 votes against; approved the say-on-pay proposal; and ratified PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending September 30, 2026. All proposals passed with strong support overall, though the equity plan amendment faced notable opposition representing about 22% of votes cast.
- ·Proposal 1 (Director Elections): Carter - 20,289,217 For, 4,634,123 Withheld; Luly - 24,728,854 For, 194,486 Withheld; 1,929,393 Broker Non-Votes.
- ·Proposal 2: 19,528,223 For, 5,390,888 Against, 4,229 Abstain.
- ·Proposal 3 (Say-on-Pay): 24,228,898 For, 692,079 Against, 2,363 Abstain.
- ·Proposal 4 (Auditors): 26,825,173 For, 26,904 Against, 656 Abstain, 0 Broker Non-Votes.
- ·Definitive proxy statement filed January 26, 2026.
12-03-2026
Sherry Barrat, a director at Arthur J. Gallagher & Co., informed the company on March 6, 2026, of her decision to retire from the Board effective May 12, 2026, upon the election of directors at the 2026 Annual Meeting of Stockholders, and she will not stand for reelection. Her retirement is not related to any disagreement with the company's operations, policies, or practices. As a result, the Board size will be reduced from ten to nine members.
- ·Filing dated March 12, 2026, reporting event of March 6, 2026.
12-03-2026
American Outdoor Brands, Inc. and its subsidiaries entered into Amendment No. 3 to the Loan and Security Agreement with TD Bank, N.A. as Agent and Lender, effective March 10, 2026, amending the original agreement dated August 24, 2020 (previously amended March 25, 2022 and November 25, 2025). The agreement governs revolving advances, letters of credit, and security interests for borrowers including AOB Products Company and Crimson Trace Corporation, with guarantors such as Battenfeld Acquisition Company Inc. and others. No specific financial terms, changes in commitments, or performance metrics are detailed in the provided filing excerpt.
- ·Filing date: March 12, 2026
- ·Original agreement date: August 24, 2020
- ·Prior amendments: March 25, 2022; November 25, 2025
12-03-2026
Crane NXT, Co. (NYSE: CXT) announced the appointment of Jeffrey Benck, President and CEO of Benchmark Electronics, to its Board of Directors, citing his over 35 years of experience in technology leadership across software, services, and hardware. Current Director James L.L. Tullis notified the Board on March 6, 2026, that he will not stand for reelection at the 2026 Annual Meeting of Stockholders on May 21, 2026. Chairman John S. Stroup praised Benck's addition while thanking Tullis for his contributions.
- ·Jeffrey Benck holds a Master of Science in management of technology from University of Miami and a Bachelor of Science in mechanical engineering from Rochester Institute of Technology.
- ·Filing date: March 12, 2026
12-03-2026
On March 6, 2026, the Board of Directors of Avanos Medical, Inc. increased the target value of the annual long-term incentive grant for Chief Executive Officer David C. Pacitti from $5M to $5.5M under the 2021 Long Term Incentive Plan, effective beginning in 2026. This represents a 10% increase in the CEO's target incentive compensation. No other changes or declines in executive compensation were reported.
- ·Form 8-K filed on March 12, 2026
- ·Securities traded as AVNS on New York Stock Exchange
12-03-2026
Laird Superfood, Inc. completed its acquisition of Navitas LLC for $38.5M, funded by a concurrent $50M private placement of Series A Convertible Preferred Stock to affiliates of Nexus Capital Management LP. The transaction, approved by stockholders at a special meeting on March 11, 2026, positions the combined entity as a scaled platform in functional nutrition with enhanced product breadth and growth potential. While executives highlighted synergies and innovation opportunities, forward-looking statements caution risks including integration challenges and inability to realize anticipated benefits.
- ·Special stockholder meeting held March 11, 2026, to approve Transactions
- ·Navitas founded in 2003 with 20+ year history in superfoods
- ·Nexus Capital Management founded in 2013
- ·Legal advisors: Haynes and Boone, LLP (Laird); Paul, Weiss, Rifkind, Wharton & Garrison LLP (Nexus); William Hood & Company, LLC (financial advisor to Navitas); Brownstein Hyatt Farber Schreck, LLP (Navitas)
12-03-2026
CACI International Inc entered into a Second Supplemental Indenture on March 12, 2026, issuing $500 million in additional 6.375% Senior Notes due 2033, increasing the total outstanding principal to $1.5 billion. The company received net proceeds of approximately $518 million, intended for repaying revolving credit facility debt used in the ARKA Group L.P. acquisition. The notes are senior unsecured, guaranteed by subsidiaries, with no reported issues in the offering process.
- ·Interest payable semi-annually on June 15 and December 15; first payment for Additional Notes on June 15, 2026, including accrued interest from December 15, 2025.
- ·Notes mature on June 15, 2033.
- ·Issued in private placement to qualified institutional buyers under Rule 144A.
- ·Base Indenture dated June 2, 2025; First Supplemental Indenture dated November 25, 2025.
12-03-2026
iRhythm Holdings, Inc. (NASDAQ: IRTC) appointed Jason Patten to its Board of Directors, effective March 12, 2026. Patten, currently Executive Vice President and Head of Enterprise Strategy at UnitedHealth Group since January 2022, brings extensive healthcare leadership experience from prior roles at UnitedHealth Group, OptumHealth, MoneyGram International, and Carlson Marketing Group. Chairman Abhi Talwalkar emphasized Patten's expertise in enterprise strategy, innovation, and partnerships to support iRhythm's growth toward a billion-dollar platform focused on AI, predictive care, and market expansion.
- ·Patten previously served as Chief Operating Officer and Senior Vice President of OptumHealth at UnitedHealth Group
- ·Patten holds an MBA in Business Administration from University of St. Thomas and a BS in Marketing from Minnesota State University, Mankato
- ·Investor Contact: Stephanie Zhadkevich (investors@irhythmtech.com)
- ·Media Contact: Kassandra Perry (mediarelations@irhythmtech.com)
12-03-2026
NCR Atleos Corporation (NYSE: NATL) announced the successful results of its consent solicitation, obtaining consents from holders of a majority in aggregate principal amount of its 9.500% Senior Secured Notes due 2029 to amend the governing indenture. On March 11, 2026, the company and its subsidiary guarantors executed a Supplemental Indenture, which became effective immediately and is binding on all noteholders. Morgan Stanley & Co. LLC and Truist Securities, Inc. served as solicitation agents, with D.F. King & Co. Inc. as the information agent.
- ·Consent Solicitation Statement dated March 5, 2026
- ·Consents valid as of March 11, 2026
- ·SEC Filing Date: March 12, 2026
12-03-2026
Axcelis Technologies, Inc. (Nasdaq: ACLS) announced David Ryzhik, Senior Vice President of Investor Relations and Corporate Strategy, as Interim Chief Financial Officer effective March 12, 2026, following James Coogan's departure to pursue a CFO role elsewhere; Coogan will remain until April 24, 2026, for a smooth transition. The company plans to engage an executive search firm for a permanent CFO hire. CEO Russell Low praised Ryzhik's expertise and his role in the pending merger with Veeco, while thanking Coogan for building a strong finance organization.
- ·David Ryzhik joined Axcelis in July 2024 with over 20 years of finance and investor relations experience.
- ·Axcelis has provided semiconductor solutions for over 45 years, headquartered in Beverly, Mass.
12-03-2026
Treasure Global Inc.'s subsidiary TADAA Technologies Sdn Bhd entered into a Software Enhancement Agreement on March 11, 2026, with Apexcode Innovations Snd Bhd to provide technology services for enhancing the Tazte Apps platform. The total contract price is RM11.7M (approximately $2.5M USD), with the first milestone payment of RM3.9M (approximately $0.83M USD); deliverables including source code must be handed over within 2 months. No immediate financial impacts or performance metrics are disclosed.
- ·Agreement includes development, upgrade, testing, deployment, and maintenance services per Appendix A
- ·Deliverables must meet Acceptance Criteria in Appendix A and be fully compatible with existing system
- ·Handover of deliverables (source code, object code, etc.) within 2 months from March 11, 2026
12-03-2026
Applied Optoelectronics, Inc. entered into Amendment No. 1 to its Equity Distribution Agreement with Raymond James & Associates, Inc. and Needham & Company, LLC, increasing the aggregate offering price for common stock from $250M to $500M. As of March 12, 2026, the Company has sold 2,476,307 shares for approximately $249,999,983, leaving roughly $250,000,017 available for future at-the-market offerings. Sales agents are entitled to 2% of gross sales prices as compensation, with the agreement terminable by either party.
- ·Shares to be sold in 'at the market' offerings via Nasdaq Global Market or other markets.
- ·Original Agreement dated February 26, 2026; prospectus supplement filed March 12, 2026.
- ·Registered under Form S-3ASR (Registration No. 333-283905).
12-03-2026
Colgate-Palmolive elected Christopher S. Boerner, Ph.D., Board Chair and CEO of Bristol Myers Squibb, to its Board effective March 15, 2026, adding expertise in pharmaceuticals and healthcare. However, director Steven A. Cahillane will not stand for reelection at the May 8, 2026 Annual Meeting due to his new role as CEO of The Kraft Heinz Company.
- ·Dr. Boerner previously served as EVP, Chief Operating Officer (2023) and EVP, Chief Commercialization Officer (2018-2023) at Bristol Myers Squibb.
- ·Dr. Boerner to receive compensation as non-employee director per proxy statement filed March 26, 2025.
- ·Filing signed by Jennifer M. Daniels on March 12, 2026.
12-03-2026
Salesforce, Inc. entered into a Master Confirmation dated March 11, 2026, for uncollared Accelerated Share Repurchase (ASR) Transactions with an unnamed Dealer, establishing the framework under ISDA 2002 Master Agreement and Equity Derivatives Definitions. Specific terms for individual Transactions, such as Prepayment Amount, Initial Shares, Trade Date, Calculation Period, and Floor Price, will be detailed in future Supplemental Confirmations. No specific transaction amounts, volumes, or performance metrics are disclosed in this filing.
- ·Governing law: New York law.
- ·Exchange: New York Stock Exchange (symbol CRM).
- ·Transactions structured as Share Forward Transactions per 2002 ISDA Equity Derivatives Definitions.
12-03-2026
Motorola Solutions, Inc. (NYSE: MSI) announced on March 12, 2026, the appointment of Peter Leav to its board of directors. Leav, a senior advisor at TPG with more than 25 years of leadership experience at software companies including McAfee (former CEO), BMC Software (former CEO), and Polycom (former CEO), brings expertise in software and cybersecurity. Chairman and CEO Greg Brown stated that Leav's track record will help drive growth as the company advances.
- ·Leav currently serves as vice chairman of the board of directors of Everfox and as a board member of New Relic.
- ·Leav previously served on the boards of Box, Proofpoint, and HD Supply.
12-03-2026
Quest Diagnostics Incorporated (NYSE: DGX) elected Timothy Wentworth, former CEO of Walgreens Boots Alliance, Evernorth Health Services, and Express Scripts, to its Board of Directors effective March 12, 2026, expanding the board to 11 members. Chairman and CEO Jim Davis highlighted Wentworth's expertise in healthcare channels, operations, and HR, while lead independent director Timothy M. Ring praised his ability to drive growth in complex healthcare companies. Quest Diagnostics serves half of U.S. physicians and hospitals and one in three American adults annually with nearly 57,000 employees.
- ·Wentworth, 65, earned a bachelor’s in industrial and labor relations from Cornell University and an associate degree in business administration from Monroe Community College.
- ·Wentworth most recently CEO of Walgreens Boots Alliance until its mid-2025 sale to Sycamore Partners; previously founding CEO of Evernorth and President/CEO of Express Scripts post-2012 Medco acquisition.
12-03-2026
On March 6, 2026, XBP Americas, LLC, a subsidiary of XBP Global Holdings, Inc., entered into a Limited Waiver and Third Amendment to its ABL Credit Agreement originally dated July 29, 2025, eliminating the covenant requiring minimum excess availability of $7.5M and temporarily increasing the advance rate for eligible investment grade billed accounts to 95.0% through September 30, 2026. However, the amendment introduces a temporary availability block through June 30, 2026, reducing borrowing capacity by the greater of $3.75M or 5.0% of the borrowing base if the fixed charge coverage ratio falls below 1.00 to 1.00, along with adjustments to borrowing base calculation and cash dominion mechanics.
- ·ABL Credit Agreement originally dated July 29, 2025; previously amended by First Amendment on Dec 19, 2025 and Second Amendment on Jan 21, 2026
- ·Fixed charge coverage ratio trigger for availability block: below 1.00 to 1.00
- ·Temporary availability block effective through June 30, 2026; advance rate increase through Sep 30, 2026
12-03-2026
Hanover Bancorp, Inc. completed a $35M private placement of fixed-to-floating rate subordinated notes due 2036 to qualified institutional buyers and accredited investors, with initial semi-annual interest at 7.25% until March 15, 2031, then resetting quarterly to 3-month SOFR plus 386 basis points. The Notes, rated BBB+ by Egan-Jones Ratings Company, qualify as Tier 2 capital and will fund the redemption of $25M existing subordinated notes at a lower rate, plus general corporate purposes including equity contributions to Hanover Community Bank. CEO Michael Puorro stated this enhances financial flexibility, capital base, and supports balance sheet growth.
- ·Notes payable semi-annually and intended to qualify as Tier 2 regulatory capital
- ·Piper Sandler & Co. as lead placement agent; Hovde Group, LLC as co-placement agent
12-03-2026
Trust Stamp Inc. (Nasdaq: IDAI) closed two strategic M&A transactions: acquiring 100% of Lexverify Ltd effective February 26, 2026, and a 50% ownership interest in Cyberfish CyberPsychology Solutions Ltd effective March 9, 2026. Both targets are alumni of the UK National Cyber Security Center (NCSC) accelerator, with expected synergies in AI-powered cybersecurity, LLM training, crisis simulations via Cyberfish's Dojo portal, and cross-selling opportunities. Leadership from both companies, including CEOs Berta Pappenheim and Dr. Cristian Gherhes, will integrate into Trust Stamp to support 2026 growth ambitions.
- ·Filing date: March 12, 2026
- ·Trust Stamp operates in sectors including banking, finance, regulatory compliance, government, healthcare, real estate, communications, and humanitarian services
12-03-2026
Firefly Neuroscience, Inc. entered a securities purchase agreement on March 8, 2026, to issue up to 13,500,000 units at $1.50 per unit, with an initial closing on March 12, 2026, for 1,500,000 units raising $2.25M from accredited investors. Investors have the option for up to $18M additional investment within 30 days, including shares or pre-funded warrants plus 5-year warrants at $1.88 and $2.50 exercise prices, subject to 4.99%/9.99% beneficial ownership limits and lock-up agreements through March 12, 2027. The private placement complies with Nasdaq rules without shareholder approval, with an S-1 registration statement due by April 15, 2026.
- ·Private placement exempt under Section 4(a)(2) and Rule 506(b) of Regulation D.
- ·Lock-Up Period: 6 months ending September 12, 2026; Leak-Out Period: 6 months ending March 12, 2027.
- ·S-1 Registration Statement to be filed by April 15, 2026, with effectiveness targeted within 45-90 days.
- ·Complies with Nasdaq Listing Rule 5635(d) without stockholder approval.
12-03-2026
Acadia Healthcare Company, Inc. (ACHC) appointed Daniel Cancelmi, former Executive Vice President and CFO of Tenet Healthcare Corporation, to its Board of Directors effective March 12, 2026. Director Wade D. Miquelon will retire at the 2026 Annual Meeting following years of service. As of December 31, 2025, Acadia operates 277 behavioral healthcare facilities with over 12,500 beds, approximately 25,000 employees serving more than 84,000 patients daily across 40 states and Puerto Rico.
- ·Appointment follows search led by Nominating and Corporate Governance Committee with executive search firm and input from Khrom Capital.
- ·Goldman Sachs and J.P. Morgan serve as financial advisors; Kirkland & Ellis LLP as legal advisor.
- ·Mr. Cancelmi's 30+ years experience includes 11 years as Tenet CFO, overseeing acquisitions like USPI and hospital divestitures.
- ·Forward-looking risks include Medicaid changes from One Big Beautiful Bill Act (OBBBA) enacted July 4, 2025.
12-03-2026
Analog Devices, Inc. held its 2026 Annual Meeting of Shareholders on March 11, 2026, resulting in the election of all ten director nominees with strong shareholder support (ranging from approximately 93% to 99% votes for). Key management proposals passed overwhelmingly, including advisory approval of named executive officer compensation (90% for), ratification of Ernst & Young LLP as auditors for fiscal year ending October 31, 2026, and approval of the Amended and Restated 2020 Equity Incentive Plan (95% for). However, the non-binding shareholder proposal on special meeting rights was rejected, receiving only 38% support.
- ·Proxy statement filed with SEC on January 23, 2026; Plan adopted by Board on December 10, 2025
- ·Broker non-votes: 30,319,338 shares across relevant proposals
12-03-2026
On March 9, 2026, Diversified Energy Company entered into an Underwriting Agreement with affiliates of EIG Global Energy Partners (Selling Stockholders) and Citigroup Global Markets Inc. for the offering of 7,501,585 shares of common stock by the Selling Stockholders. The offering closed on March 11, 2026, with the Company repurchasing 3,750,000 shares at the underwriter's purchase price, receiving no proceeds from the sale. No performance metrics or period comparisons were reported.
- ·Underwriting Agreement filed as Exhibit 1.1
- ·Agreement includes customary indemnification provisions
12-03-2026
Quest Resource Holding Corporation (as Holdings), along with subsidiaries Quest Resource Management Group, LLC and Quest Equipment, LLC (as Borrowers), entered into a Loan and Security Agreement with Texas Capital Bank (as Lender) dated March 12, 2026, providing for revolving loans, advances, and letters of credit secured by collateral including accounts, inventory, and equipment. The agreement includes financial covenants such as Minimum Fixed Charge Coverage Ratio and Maximum Senior Net Leverage Ratio, with Applicable Margins for Term SOFR Loans ranging from 1.75% to 2.75% based on leverage levels. No specific commitment amounts or borrowing base details are provided in the filing excerpt.
- ·Filing includes Items 1.01 (Entry into Material Definitive Agreement), 1.02, 2.03 (Creation of Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits).
- ·Agreement features include Availability based on Line Cap minus Revolving Credit Exposure, with Availability Reserves at Lender's discretion.
- ·Financial covenants in Article 9: Minimum Fixed Charge Coverage and Maximum Senior Net Leverage Ratio, with Equity Cure option.
12-03-2026
Applife Digital Solutions, Inc. entered into a Securities Purchase Agreement dated March 9, 2026, with Proactive Capital Partners, LP, for the issuance and sale of a convertible Note under the exemption of Section 4(a)(2) of the 1933 Act and Rule 506(b). The agreement includes covenants requiring the Company to deliver irrevocable transfer agent instructions, purchase D&O insurance within 180 days of closing with 18 months coverage and 2-year tail, and pay $3,000 per day in liquidated damages for failure to disclose material non-public information via Form 8-K. No purchase price, note principal, or financial performance metrics are detailed in the filing excerpt.
- ·Agreement filed as EX-10.1 with 8-K on March 12, 2026, covering Items 1.01 (Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits).
- ·Company must provide corporate resolutions and issuance approvals to transfer agent within 6 hours of each Note conversion.
- ·Conditions include no Material Adverse Effect, no trading suspension, and delivery of good standing certificates within 10 days of Closing.
- ·Governing law is Nevada; arbitration and venue in Orange County, California.
12-03-2026
BRC Group Holdings, Inc. announced transactions resulting in the retirement of approximately $37.9 million in outstanding debt through bond-for-equity exchanges of 1,343,551 senior note units for 4,201,300 shares of common stock and cash repurchases of 171,703 units of 5.0% senior notes for $4.0 million, with a final transaction closing March 13, 2026. The company will redeem $96 million of 5.50% Senior Notes due 2026 (RILYK) on March 30, 2026, further reducing net debt beyond preliminary year-end 2025 estimates. However, due to a new auditor onboarding in September 2025 and recent 10-Q filings, the company will file a Form 12b-25 by March 17, 2026, extending the 2025 Annual Report (10-K) deadline to March 31, 2026.
- ·Transactions conducted with long-time institutional investor pursuant to Section 3(a)(9) of the Securities Act of 1933
- ·Three Quarterly Reports on Form 10-Q filed between November 20, 2025, and January 14, 2026
- ·Q4 and Full Year 2025 Financial Results and earnings call to be announced next week, with release by March 31, 2026
12-03-2026
ScanSource, Inc. announced executive changes effective March 16, 2026, with Alexandre Conde transitioning from Senior Executive Vice President, Chief People Officer to Senior Executive Vice President, Strategy. The company hired Michael Webb as its new Senior Executive Vice President, Chief Human Resources Officer, effective the same date, with the hiring occurring on March 6, 2026. The filing was signed by Michael L. Baur, President & Chief Executive Officer.
- ·Filing date: March 12, 2026
- ·Date of earliest event reported: March 6, 2026
12-03-2026
On March 6, 2026, First United Corporation's Compensation Committee revised the Long-Term Incentive Plan (LTIP) performance-vesting RSUs to use ROAE and TBVPSG metrics relative to the 25th, 50th, and 75th percentiles of a peer group of 103 banks with $1.0B-$4.2B in assets. The Committee also approved 2026 Short-Term Incentive Plan (STIP) opportunities for executives Jason B. Rush (target $142,500), Tonya K. Sturm (target $73,593), and Robert L. Fisher, II (target $78,693), based on ROAA, efficiency ratio, delinquencies, and individual performance. No financial results or performance outcomes were reported.
- ·LTIP performance period ends December 31, 2028; RSU values based on percentage of base salary as of December 31, 2025.
- ·Peer group for LTIP is closed; acquired peers removed, failed peers assigned -99% performance.
- ·STIP payouts for 2026 to be paid in 2027; specific officer metrics confidential until 2026 results determined.
- ·STIP metrics: return on average assets, efficiency ratio, average delinquencies as percentage of total loans, individual performance.
12-03-2026
Non-Invasive Monitoring Systems, Inc. (NIMU), a Florida corporation, entered into an Agreement and Plan of Merger and Reorganization dated March 6, 2026, whereby its wholly-owned subsidiary, Gravitics Merger Sub, Inc., will merge with Gravitics, Inc., with Gravitics surviving as a wholly-owned subsidiary and its stockholders receiving at least 95.5% of NIMU's post-merger equity. This represents significant dilution for existing NIMU stockholders, who will retain no more than 4.5% ownership. The closing is targeted on or before June 30, 2026, at the offices of Lucosky Brookman LLP, with Colin Doughan to serve as Chairman of the post-merger board.
- ·Merger intended to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.
- ·Effective Time upon filing Certificate of Merger with Delaware Secretary of State pursuant to DGCL Section 251(c).
- ·Post-merger board to include a majority of independent directors under Nasdaq Rule 5605(a)(2).
12-03-2026
NGL Energy Partners LP closed a new seven-year $950M senior secured term loan (increased from $687.8M with $250M incremental financing), with proceeds to repay the existing term loan, redeem approximately 195,000 Class D Preferred Units (leaving ~316,000 outstanding), and for general corporate purposes. The asset-based revolving credit facility was amended, reducing commitments from $475M to $425M. CEO Mike Krimbill highlighted this as a step toward a simpler capital structure, though the ABL reduction limits liquidity flexibility.
- ·Filing date: March 12, 2026
- ·Involves Items 1.01 (Material Definitive Agreement), 2.03 (Direct Financial Obligation), 7.01 (Regulation FD), and 9.01 (Financial Statements)
12-03-2026
The Chemours Company completed a private offering of $700M aggregate principal amount of 7.875% senior unsecured notes due 2034, using net proceeds and cash on hand to redeem $188M of its 5.750% senior notes due 2028 at approximately $189.8M plus accrued interest. Remaining proceeds are expected to fund the redemption of its outstanding 5.375% senior notes due 2027 at approximately $500.3M plus accrued interest, extending maturities but at a higher interest rate compared to the redeemed notes.
- ·Headquartered in Wilmington, Delaware; listed on NYSE under symbol CC.
- ·Operates three businesses: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.
- ·Notes offered to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S; not registered under Securities Act.
12-03-2026
On March 9, 2026, FedEx Corporation's Board of Directors approved amendments to its FY25–FY27 and FY26–FY28 long-term incentive plans (LTI Plans) to address the impact of the planned FedEx Freight spin-off on June 1, 2026, and the shift in fiscal year end from May 31 to December 31 effective the same date. The amendments measure actual performance through FY26 and assume 100% target performance for remaining periods, resulting in weighted payouts of 67% actual/33% target for FY25–FY27 and 33% actual/67% target for FY26–FY28. These changes apply to named executive officers (NEOs) and other employees remaining with the company post-spin-off, with no alterations to underlying performance metrics.
- ·Amendments approved by Compensation and Human Resources Committee recommendation
- ·Payouts for FY25–FY27 after May 31, 2027; for FY26–FY28 after May 31, 2028
- ·Details on LTI Plans in 2025 Proxy Statement filed August 18, 2025, pages 55-60
12-03-2026
Digimarc Corporation entered into an Agreement and Plan of Reorganization dated March 12, 2026, with Deschutes Parent, Inc. (Holdings) and Deschutes Merger Sub, Inc. (Merger Sub) to restructure into a holding company via a merger followed by conversion of the Company to an Oregon LLC wholly owned by Holdings, with shareholders exchanging shares on a 1:1 basis. Post-reorganization, Holdings will rename to Digimarc Corporation and assume the Company's 2008 and 2018 Incentive Plans. The transaction requires shareholder approval at the annual meeting and has no immediate financial impacts disclosed.
- ·Merger effective upon filing Articles of Merger with Oregon Secretary of State; Conversion effective 12:01 A.M. PT the following day.
- ·Each share of Merger Sub Common Stock converts to one share of Company Common Stock, making Holdings sole shareholder pre-Conversion.
- ·Holdings authorized capital matches Company: 50M common shares and 2.5M preferred shares at $0.001 par value.
12-03-2026
CNL Strategic Residential Credit, Inc. entered into an Amended and Restated Advisory Agreement with CNL Residential Credit Manager, LLC on March 10, 2026, primarily changing the accrual frequency of the Total Return Incentive Fee from quarterly to monthly, with a term until March 10, 2027 subject to board renewal. The company also executed an Amended and Restated Managing Dealer Agreement on March 12, 2026, with CNL Securities Corp. and the Advisor, and a related Form of Participating Broker Agreement, to reflect a shift in its ongoing Private Offering of common stock from Rule 506(b) to Rule 506(c) under Regulation D. No financial impacts or performance metrics are disclosed in the filing.
12-03-2026
Paycom Payroll, LLC, a subsidiary of Paycom Software, Inc., entered into an Increasing Lender Supplement dated March 12, 2026, to its Credit Agreement originally dated July 29, 2022, administered by JPMorgan Chase Bank, N.A. Several lenders, including JPMorgan Chase Bank, N.A., BMO Bank N.A., PNC Bank, National Association, U.S. Bank National Association, Wells Fargo Bank, National Association, Bank of America, N.A., and Truist Bank, agreed to increase their Revolving Commitments, with total commitments updated per Schedules A and B (amounts not specified in filing). The Borrower confirmed no Default or Event of Default exists, enhancing liquidity access without noted drawbacks.
- ·Credit Agreement originally dated July 29, 2022
- ·Supplement governed by laws of the State of New York
12-03-2026
Matson, Inc. announced that John P. Lauer, Executive Vice President and Chief Commercial Officer, notified the company on March 9, 2026, of his planned retirement effective July 1, 2026. This is a routine executive transition with no additional details on successor or impact provided. No financial or operational metrics were disclosed.
- ·Filing Date: March 12, 2026
- ·Date of Earliest Event Reported: March 9, 2026
- ·SEC Items Reported: 5.02 (Departure of Directors or Certain Officers), 9.01 (Financial Statements and Exhibits)
12-03-2026
LQR House Inc. entered into a Sales Agreement with A.G.P./Alliance Global Partners on March 11, 2026, enabling the company to offer and sell up to $50.3M of common stock through an at-the-market (ATM) offering pursuant to its Form F-3 Registration Statement (File No. 333-282118). Proceeds are expected to fund capital expenditures, potential acquisitions, sales and marketing, working capital, and general corporate purposes. The Sales Agent will receive a 3.0% commission on gross proceeds, with no obligation for the company to sell any shares.
- ·Agreement dated March 11, 2026; filed March 12, 2026
- ·Sales pursuant to Registration Statement on Form F-3 (File No. 333-282118) and prospectus supplement dated March 11, 2026
- ·Sales Agreement attached as Exhibit 10.1
12-03-2026
IGC Pharma, Inc. entered into a Securities Purchase Agreement dated March 5, 2026, with Vanquish Funding Group Inc. for the issuance of a bridge note with an aggregate principal amount of $353,050 (including $46,050 OID), closing on or about March 6, 2026, with potential additional tranches up to $2,015,000 over the next 12 months. The note is convertible into common stock, posing potential dilution risk to existing shareholders given 92,868,241 shares outstanding out of 600,000,000 authorized. This unregistered securities offering relies on exemptions under the 1933 Act, providing short-term financing but at a costly OID.
- ·Agreement relies on SEC exemptions under the 1933 Act for unregistered sale.
- ·No material adverse changes since September 30, 2025, per company representations.
- ·Buyer is an accredited investor; securities may bear restrictive legends.
12-03-2026
Southwest Airlines Co. entered into a $500M senior secured term loan credit facility with BNP Paribas on March 11, 2026, which was fully drawn on closing and matures on March 11, 2029. The facility allows prepayments without penalty and includes an uncommitted incremental feature for up to an additional $500M. It is secured by certain aircraft and related assets, with interest at Term SOFR + 1.10% (floor 0.00%) or Alternate Base Rate + 0.10% (floor 1.00%).
- ·Amounts prepaid under the facility may not be reborrowed.
- ·The facility includes customary covenants, representations, warranties, and events of default, with a minimum collateral coverage ratio requirement.
- ·The full Term Loan Credit Agreement will be filed in the Quarterly Report for the fiscal quarter ending March 31, 2026.
12-03-2026
Activate Energy Acquisition Corp., a blank check company, announced the resignation of director Andrew Childs on February 1, 2026, effective immediately and not due to any disagreement with the company. On March 4, 2026, the Board appointed Paul Moore, an oil/gas upstream expert with experience at Todd Corporation, Santos Limited, and Woodside Petroleum, and Keith Byer, a former Deloitte Senior Managing Director specializing in finance and risk, as new directors effective immediately. There are no arrangements, family relationships, or material interests involving the new directors.
- ·Company is an emerging growth company incorporated in Cayman Islands, listed on Nasdaq Global Market.
- ·Resignation of Andrew Childs unrelated to operations, policies, or practices.
- ·New directors have no family relationships with other directors/officers or material interests under Item 404(a).
12-03-2026
Plum Acquisition Corp. IV, a Cayman Islands SPAC, entered into a Business Combination Agreement dated March 8, 2026, with Controlled Thermal Resources Holdings Inc. and its merger sub, outlining a domestication to Delaware followed by a merger where the target survives. Supporting Company Stockholders representing at least 60% of votes have committed to approve the transaction via Transaction Support Agreements. No financial terms such as valuation, share exchange ratios, or PIPE amounts are disclosed in the filing.
- ·Agreement executed March 8, 2026; SEC 8-K filed March 12, 2026.
- ·Domestication to occur at least two business days prior to Closing.
- ·Transaction includes Registration Rights Agreement and Lock-Up Agreement at Closing.
- ·Intended tax treatment as tax-free reorganizations under Section 368 of the Code.
12-03-2026
CareCloud, Inc. (CCLDO) filed an 8-K on March 12, 2026, reporting results of operations and financial condition (Item 2.02), departure or appointment of officers (Item 5.02), Regulation FD disclosure (Item 7.01), and exhibits including EX-99.1 (Item 9.01). The filing references unregistered securities sale and preliminary officer change events, but no specific financial metrics, performance comparisons, or detailed changes are provided in the available content excerpt. No positive or negative quantitative shifts identifiable due to lack of data.
- ·Filing items: 2.02 (Results of Operations), 5.02 (Officer Changes), 7.01 (Reg FD Disclosure), 9.01 (Exhibits including EX-99.1)
- ·Subcategory noted: Unregistered Securities Sale
12-03-2026
Sleep Number Corporation (SNBR) appointed Kelly F. Baker, 41, as its Controller and Principal Accounting Officer effective March 11, 2026, ending her interim role that began July 21, 2025; she has served as Controller since February 2025. Baker brings prior experience as Controller at Miromatrix Medical, Inc. (a subsidiary of United Therapeutics Corporation) from December 2021 to January 2025, and roles at Donaldson Company, Inc., The Tile Shop, and Virtual Radiologic Corporation. There are no related party transactions or special arrangements associated with the appointment.
- ·Baker served as Controller at Miromatrix Medical from December 2021 to January 2025.
- ·Baker held finance positions at Donaldson Company from February 2020 to December 2021, The Tile Shop from May 2014 to December 2019, and Virtual Radiologic from September 2007 to May 2014.
- ·Baker holds a bachelor’s degree in accounting and management from the College of Saint Benedict and an MBA from the University of Minnesota, Carlson School of Management; she is a Certified Public Accountant.
12-03-2026
USA Rare Earth, Inc. filed an 8-K on 2026-03-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the officer position affected, nature of the change (appointment or resignation), reasons, timing, or any quantitative financial metrics are disclosed.
- ·Data completeness: LOW (<50%). Critical missing information: Officer name, title (e.g., CEO/CFO), action (appointment/resignation/retirement), effective date, stated reason for change, board composition impact, details on Reg FD disclosure, other events, and exhibits listed.
12-03-2026
Build-A-Bear Workshop (NYSE: BBW) announced a planned CEO succession: longtime CEO Sharon Price John to retire effective June 11, 2026, with Chief Operations and Experience Officer Chris Hurt appointed as successor following a transition period; Hurt will also join the Board. The move concludes a multi-year succession process aided by a consulting firm, highlighting Hurt's role in the company's turnaround, global expansion, and 5th consecutive record fiscal 2025 with $529.8M revenues. Price John will remain on the Board to support the transition.
- ·Hurt joined Build-A-Bear in 2015; Price John since 2013.
- ·Company founded in 1997; nearing 30 years of operations.
- ·Investor Relations contact: garys@buildabear.com; Media: pr@buildabear.com
12-03-2026
Beneficient appointed Mack H. Hicks, CEO of Hicks Holdings LLC and experienced private equity executive, to its Board of Directors on March 12, 2026, to continue the legacy of his late father Thomas O. Hicks, former Chairman. Separately, the company amended a prior credit agreement with a Hicks affiliate on March 10, 2026, settling approximately $1.66M in remaining accrued interest, fees, and expenses via $572,588 in Class A common stock and deferred cash payments of $94,365 (due March 31, 2026) and $1M (due September 30, 2026), enhancing near-term financial flexibility and liquidity preservation. No declines or flat metrics reported.
- ·Original credit agreement dated October 19, 2023
- ·Amendment to credit agreement dated March 10, 2026
- ·Thomas O. Hicks passed away in December 2025
- ·Hicks serves on boards of Standard Industrial Manufacturing, Bucked Up, Face Haus, Vayner Sports, and Accresa Health
- ·Hicks holds BA from University of Texas at Austin and completed Harvard Owner/President Management Program
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)